Cancer Drug Co. Founder Accuses Brace Of Takeover Plot
The founder of cancer drug development firm Tyrogenex Inc. launched a derivative complaint in the Delaware Chancery Court on Tuesday claiming majority stakeholder Brace Pharmaceuticals LLC and several accomplices took over...To view the full article, register now.
Already a subscriber? Click here to view full article